ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Ovarian Epithelial Carcinoma
Triple Negative Breast Cancer
Adenocarcinoma

Endometrial Cancer trials near Paris, Île-de-France, FRA:

Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO)

The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. E ...

Enrolling
Endometrial Cancer
Drug: Megestrol Acetate
Drug: Durvalumab

Phase 2, Phase 3

Leiden University Medical Center (LUMC)

Villejuif, France and 13 other locations

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Doxorubicin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Paris, France and 121 other locations

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Enrolling
Endometrial Cancer
Drug: INCAGN02385
Drug: pemigatinib

Phase 2

Incyte
Incyte

Paris, France and 67 other locations

study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...

Enrolling
Endometrial Cancer
Drug: Dostarlimab
Drug: Carboplatin-Paclitaxel

Phase 3

ARCAGY/ GINECO GROUP

Paris, France and 58 other locations

non-resectable metastatic or locally advanced non-colorectal and non-endometrial cancers compared to the standard of care chemother...

Not yet enrolling
Soft Tissue Sarcoma
Adrenocortical Carcinoma
Drug: Dostarlimab
Drug: Chemotherapy

Phase 2

Unicancer
Unicancer

Paris, Île-de-France, France and 21 other locations

drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

Paris, France and 75 other locations

choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...

Active, not recruiting
Endometrial Neoplasms
Drug: Pembrolizumab
Drug: Doxorubicin

Phase 3

Eisai
Eisai

Paris, France and 168 other locations

This interventional study will evaluate the efficacy and safety of ART0380 as monotherapy in patients whose tumors have a biology to predict for sens...

Enrolling
Metastatic Cancer
Recurrent Endometrial Cancer
Drug: ART0380

Phase 2

Artios Pharma

Paris, NAP, France and 14 other locations

A first-in-human study using BDC-1001 as a single agent and in combination with nivolumab in HER2 expressing advanced malignancies

Active, not recruiting
HER2-positive Endometrial Cancer
HER2-positive Colorectal Cancer
Drug: BDC-1001
Drug: Nivolumab

Phase 1, Phase 2

Bolt Biotherapeutics

Paris, France and 25 other locations

TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: Carboplatin
Drug: Leucovorin LV

Phase 2

AstraZeneca
AstraZeneca

Suresnes, France and 92 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems